Brexogen's Exosome Therapy for Atopic Dermatitis, 'BRE-AD01' A...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SEOUL, South Korea, Nov. 7, 2022 /PRNewswire-AsiaNet/ -- First entry to clinical trial of exosome for atopic dermatitisThe first exosome-based therapeutics in US clinical trial among Korean companiesThe US FDA granted the initiation of the phase 1 clinical trial of 'BRE-AD01', an exosome- based ...
Authors: LATEST ASIANET NEWS RELEASES